castration-resistant prostate cancer

Medivation Inc (NASDAQ: MDVN) is up roughly 2 percent on Tuesday, trading at $37.68. According to the UK's financial outlet This Is Money, Medivation may be courting suitors. Among the names that have begun circulating as interested parties are AstraZeneca plc (ADR) (NYSE: AZN), Sanofi SA (ADR) (...